Actively Recruiting

Age: 1Week - 100Years
All Genders
Healthy Volunteers
ID00478712

Genetic Analysis of Hirschsprung Disease

Led by NYU Langone Health · Updated on 2026-06-04

3000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

N

NYU Langone Health

Lead Sponsor

N

New York University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Hirschsprung disease is a genetic birth defect caused by the absence of nerve cells in parts of the intestines, affecting about 1 in 5000 live births. This condition may occur alone or alongside other birth defects such as Down syndrome and deafness. Researchers are studying the complex genetic factors behind Hirschsprung disease to identify specific gene mutations and understand how these genes influence the disease in families and individuals. The study involves collecting blood, saliva, or DNA samples from individuals with Hirschsprung disease and their relatives. Researchers will analyze these samples using whole genome mapping and sequencing to find genetic variations linked to the disease. Participants will also provide medical and family history information, and access to medical records will be requested to explore how genetic differences relate to clinical outcomes. Participants will complete questionnaires and provide biological samples, which will be used for DNA isolation and possibly cell line creation. Researchers will gather clinical data related to pathology and surgery to examine correlations between genetic variants and disease features. The study includes long-term follow-up to monitor outcomes such as the need for repeat surgeries and bowel control issues, with data collection continuing for up to 100 years after enrollment.

CONDITIONS

Brief Title

Hirschsprung Disease Genetic Study

Who Can Participate

Age: 1Week - 100Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals with Hirschsprung disease and their first degree relatives
  • Any segment length of disease
  • May have other congenital anomalies or health problems
  • May be single or multiple affected individuals in the family
  • Ages between 1 year and 100 years
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide a sample for genetic studies
  • Unable to comprehend and provide informed consent (individual, parent, or guardian)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Diagnostic Evaluation

Duration - Up to 1 year

Participants provide medical and family history information and submit blood or saliva samples for genetic analysis related to Hirschsprung disease.

1 to 2 visits depending on sample and data collection

Long-term Monitoring

Duration - Up to 100 years

Participants' clinical outcomes and genetic data are monitored over time to study correlations with disease characteristics and treatment outcomes.

Periodic assessments depending on clinical follow-up

Trial Site Locations

Total: 1 location

1

New York University School of Medicine

New York, New York, United States, 10016

Actively Recruiting

Loading map...

Research Team

J

Jenna Pucel, MS, CGC

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Investigating the Interaction of the Enteric Nervous System ...

Hirschsprung Disease

Actively Recruiting

1 location

Impact of Providing Nursing Support on Parental Stress Relat...

Hirschsprung Disease

Actively Recruiting

1 location

Stimulation Modeling and Adaptive Response Tracking in Pedia...

Gastrointestinal Motility Disorders in Children

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome-Hirschsprung disease association.

Stacey Arnold, Anna Pelet, Jeanne Amiel...

https://pubmed.ncbi.nlm.nih.gov/19306335

Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability.

Eileen Sproat Emison, Merce Garcia-Barcelo, Elizabeth A Grice...

https://pubmed.ncbi.nlm.nih.gov/20598273

Population variation in total genetic risk of Hirschsprung disease from common RET, SEMA3 and NRG1 susceptibility polymorphisms.

Ashish Kapoor, Qian Jiang, Sumantra Chatterjee...

https://pubmed.ncbi.nlm.nih.gov/25666438

Enhancer Variants Synergistically Drive Dysfunction of a Gene Regulatory Network In Hirschsprung Disease.

Sumantra Chatterjee, Ashish Kapoor, Jennifer A Akiyama...

https://pubmed.ncbi.nlm.nih.gov/27693352